%0 Journal Article
%T Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
%A Joanna Stein-Fishbein
%A Joshua C Berkowitz
%A Keith S Sultan
%A Richard Furie
%A Sundas Khan
%J Archive of "World Journal of Gastrointestinal Pharmacology and Therapeutics".
%D 2018
%R 10.4292/wjgpt.v9.i1.8
%K Crohn¡¯s disease
%K Ulcerative colitis
%K Infliximab
%K Azathioprine
%K Inflammatory bowel disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797978/